tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ALNY Stock Latest News

Alnylam’s Phase 2 CAA Study: A Potential Game-Changer in Neurological Treatments
Company AnnouncementsAlnylam’s Phase 2 CAA Study: A Potential Game-Changer in Neurological Treatments
1d ago
ALNY
Alnylam Pharmaceuticals’ ELEVATE Study: A Closer Look at AHP Management
PremiumCompany Announcements
Alnylam Pharmaceuticals’ ELEVATE Study: A Closer Look at AHP Management
3d ago
ALNY
Alnylam’s ALN-APP Study: A Promising Step in Alzheimer’s Treatment
PremiumCompany Announcements
Alnylam’s ALN-APP Study: A Promising Step in Alzheimer’s Treatment
3d ago
ALNY
Alnylam’s NeuroFeeL Study: A Potential Game-Changer for hATTR Amyloidosis
PremiumCompany Announcements
Alnylam’s NeuroFeeL Study: A Potential Game-Changer for hATTR Amyloidosis
3d ago
ALNY
Alnylam’s ConTTRibute Study: A Closer Look at Real-World Impact on ATTR Amyloidosis
PremiumCompany Announcements
Alnylam’s ConTTRibute Study: A Closer Look at Real-World Impact on ATTR Amyloidosis
3d ago
ALNY
Alnylam’s ALN-HTT02 Study: A Potential Game-Changer for Huntington’s Disease
PremiumCompany AnnouncementsAlnylam’s ALN-HTT02 Study: A Potential Game-Changer for Huntington’s Disease
3d ago
ALNY
Alnylam’s Patisiran-LNP Study: Key Insights for Investors
Premium
Company Announcements
Alnylam’s Patisiran-LNP Study: Key Insights for Investors
3d ago
ALNY
Alnylam’s Innovative Approach in Liver Cancer Treatment: A Phase 1 Study Update
Premium
Company Announcements
Alnylam’s Innovative Approach in Liver Cancer Treatment: A Phase 1 Study Update
3d ago
ALNY
Alnylam’s Vutrisiran Study: A Potential Game-Changer for ATTR Amyloidosis Treatment?
PremiumCompany Announcements
Alnylam’s Vutrisiran Study: A Potential Game-Changer for ATTR Amyloidosis Treatment?
16d ago
ALNY
Alnylam’s Vutrisiran Study: A Potential Game-Changer for Cardiomyopathy Treatment
PremiumCompany Announcements
Alnylam’s Vutrisiran Study: A Potential Game-Changer for Cardiomyopathy Treatment
18d ago
ALNY
Alnylam price target raised to $570 from $500 at H.C. Wainwright
PremiumThe Fly
Alnylam price target raised to $570 from $500 at H.C. Wainwright
23d ago
ALNY
Alnylam Pharma: Strong Commercial Performance and Promising Pipeline Drive Buy Rating
PremiumRatings
Alnylam Pharma: Strong Commercial Performance and Promising Pipeline Drive Buy Rating
23d ago
ALNY
Alnylam Pharma: Strong Growth Prospects and Transition to Profitability Support Buy Rating
PremiumRatingsAlnylam Pharma: Strong Growth Prospects and Transition to Profitability Support Buy Rating
24d ago
ALNY
Alnylam price target raised to $475 from $348 at JPMorgan
Premium
The Fly
Alnylam price target raised to $475 from $348 at JPMorgan
24d ago
ALNY
Coinbase downgraded, Spotify upgraded: Wall Street’s top analyst calls
Premium
The Fly
Coinbase downgraded, Spotify upgraded: Wall Street’s top analyst calls
26d ago
AVB
BAX
Alnylam upgraded to Peer Perform from Underperform at Wolfe Research
PremiumThe Fly
Alnylam upgraded to Peer Perform from Underperform at Wolfe Research
26d ago
ALNY
Oppenheimer upgrades Alnylam to Outperform on Amvuttra launch
PremiumThe Fly
Oppenheimer upgrades Alnylam to Outperform on Amvuttra launch
26d ago
ALNY
Alnylam upgraded to Outperform from Perform at Oppenheimer
PremiumThe Fly
Alnylam upgraded to Outperform from Perform at Oppenheimer
26d ago
ALNY
Alnylam Pharma: Hold Rating Amid Strong Sales and Elevated Costs
PremiumRatings
Alnylam Pharma: Hold Rating Amid Strong Sales and Elevated Costs
26d ago
ALNY
Alnylam’s Q2 2025 Earnings Call Highlights Robust Growth
PremiumCompany AnnouncementsAlnylam’s Q2 2025 Earnings Call Highlights Robust Growth
29d ago
ALNY
Alnylam price target raised to $459 from $385 at Truist
Premium
The Fly
Alnylam price target raised to $459 from $385 at Truist
29d ago
ALNY
Alnylam price target raised to $450 from $342 at Scotiabank
Premium
The Fly
Alnylam price target raised to $450 from $342 at Scotiabank
29d ago
ALNY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >